Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women

References

• Ciotta L, Stracquadanio M, Pagano I, et al. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci 2011;15:509–14.
   PubMed Web of Science ®Google Scholar
• Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352:1223–36.
   PubMed Web of Science ®Google Scholar
• Dumont A, Robin G, Catteau-Jonard S, Dewailly D. Role of anti-mullerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review. Reprod Biol Endocrinol 2015; 13:137.
   PubMed Web of Science ®Google Scholar
• Diefer DB. Age-specific serum anti-mullerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril 2011;95:747–50.
   PubMed Web of Science ®Google Scholar
• Picard JY, Josso N. Purification of testicular AMH allowing direct visualization of the pure glycoprotein and determination of the yield and purification factor. Mol Cell Endocrinol 1984;12:17–30.
   Web of Science ®Google Scholar
• Lee MM, Misra M, Donahoe PK, et al. MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol Cell Endocrinol 2003;211:91–8.
   PubMed Web of Science ®Google Scholar
• Catteau-Jonard S, Jasmin SP, Leclerc A, et al. Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008;93:4456–61.
   PubMed Web of Science ®Google Scholar
• Revelli A, Delle Piane L, Casano S, et al. Follicular fluid content and oocyte quality from single biochemical markers to metabolomics. Reprod Biol Endocrinol 2009;7:40.
   PubMed Web of Science ®Google Scholar
• Cate RL, Mattaliano RJ, Hession C, et al. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 1986;45:685–98.
   PubMed Web of Science ®Google Scholar
• Schenk M, Kropfl JM, Obermayer-Pietsch B, et al. Anti-Mullerian hormone concentrations in individual follicular fluids within one stimulated IVF cycle resemble blood serum values. J Assist Reprod Genet 2017;34:1115–20.
   PubMed Web of Science ®Google Scholar
• Catteau-Jonard S, Dewailly D. Anti-Mullerian hormone and polycystic ovary syndrome. Gynecol Obstet Fertil 2011;39:514–17.
   PubMedGoogle Scholar
• Eilertsen TB, Vanky E, Carlsen SM, et al. Anti-mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod 2012;27:2494–502.
   PubMed Web of Science ®Google Scholar
• Tomova A, Deepinder F, Robeva R, et al. Anti-Müllerian hormone in women with polycystic ovary syndrome before and after therapy with metformin. Horm Metab Res 2011;43:723–7.
   PubMed Web of Science ®Google Scholar
• Neagu M, Cristescu C. Antimullerian hormone – a prognostic marker for metformin therapy efficiency in the treatment of women with infertility and polycystic ovary syndrome. J Med Life 2012;5:462–4.
   PubMedGoogle Scholar
• Fulghesu AM, Villa P, Pavone V, et al. The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:644–8.
   PubMed Web of Science ®Google Scholar
• Pawelczak M, Kenigsberg L, Milla S, et al. Elevated serum anti-Mullerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features. J Pediatr Endocrinol Metab 2012;25:983–9.
   PubMed Web of Science ®Google Scholar
• Li Y, Ma Y, Chen X, et al. Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism. J Assist Reprod Genet 2012;29:1147–51.
   PubMed Web of Science ®Google Scholar
• Woo H-Y, Kim K-H, Rhee E-J, et al. Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome. Endocr J 2012;59:781–90.
   PubMed Web of Science ®Google Scholar
• Piouka A, Farmakiotis D, Katsikis I, et al. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab 2009;296:E238–43.
   PubMed Web of Science ®Google Scholar
• Rosenfield RL, Wroblewski K, Padmanabhan V, et al. Antimullerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril 2012;98:242–9.
   PubMed Web of Science ®Google Scholar
• Dewailly D, Gronier H, Poncelet E, et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod 2011;26:3123–9.
   PubMed Web of Science ®Google Scholar
• Lin YH, Chiu WC, Wu CH, et al. Antimüllerian hormone and polycystic ovary syndrome. Fertil Steril 2011;96:230–5.
   PubMed Web of Science ®Google Scholar
• Revelli A, Biasoni V, Gennarelli G, et al. IVF results in patients with very low serum AMH are significantly affected by chronological age. J Assist Reprod Genet 2016;33:603–9.
   PubMed Web of Science ®Google Scholar
• Tremellen K, Zander-Fox D. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan. Aust N Z J Obstet Gynaecol 2015;55:384–9.
   PubMed Web of Science ®Google Scholar
• Basuino L, Silveira CF. Human follicular fluid and effects on reproduction. JBRA Assist Reprod 2016;20:38–40.
   PubMed Web of Science ®Google Scholar
• Kim JH, Lee JR, Chang HJ, et al. Anti-Mullerian hormone levels in the follicular fluid of the preoculatory follicle: a predictor for oocyte fertilization and quality of embryo. J Korean Med Sci 2014;29:1266–70.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised (2003) consensus on diagnostic criteria and long- term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
   Web of Science ®Google Scholar
• Kriseman M, Mills C, Kovanci E, et al. Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome. J Assist Reprod Genet 2015;32:1313–16.
   PubMed Web of Science ®Google Scholar
• Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002;143:1076–84.
   PubMed Web of Science ®Google Scholar
• Ueno S, Manganaro TF, Donahoe PK. Human recombinant mullerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro. Endocrinology 1988;123:1652–9.
   PubMed Web of Science ®Google Scholar
• Kim JH, Seibel MM, MacLaughlin DT, et al. The inhibitory effects of mullerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells. J Clin Endocrinol Metab 1992;75:911–17.
   PubMed Web of Science ®Google Scholar
• Kedem A, Yung Y, Yerushalmi GM, et al. Anti Müllerian hormone (AMH) level and expression in mural and cumulus cells in relation to age. J Ovarian Res 2014;7:113.
   PubMed Web of Science ®Google Scholar
• Kedem A, Hourvitz A, Yung Y, et al. Anti-Mullerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory PCOS patients undergoing in vitro maturation (IVM) treatments. Gynecol Endocrinol 2013;29:651–6.
   PubMed Web of Science ®Google Scholar
• Koninger A, Sauter L, Edimiris P, et al. Predictive markers for the FSH sensitivity of women with polycystic ovary syndrome. Hum Reprod 2014;29:518–24.
   PubMed Web of Science ®Google Scholar
• Nelson SM, Yates RW, Lyall H, et al. Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod 2009;24:867–75.
   PubMed Web of Science ®Google Scholar
• Fanchin R, Schonauer LM, Righini C, et al. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 2003;18:323–7.
   PubMed Web of Science ®Google Scholar
• Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-Müllerian hormone: a new marker for ovarian function. Reproduction 2006;131:1–9.
   PubMed Web of Science ®Google Scholar
• La Marca A, Volpe A. AntiMüllerian serum levels during pregnancy. Clin Endocrinol (Oxf) 2006;64:715–6.
   PubMed Web of Science ®Google Scholar
• Bath LE, Wallace WH, Shaw MP, et al. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003;18:2368–74.
   PubMed Web of Science ®Google Scholar
• Eldar-Geva T, Ben-Chetrit A, Spitz IM, et al. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod 2005;20:3178–83.
   PubMed Web of Science ®Google Scholar
• Arabzadeh S, Hossein G, Rashidi BH, et al. Comparing serum basal and follicular fluid levels of anti-Müllerian hormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome. Ann Saudi Med 2010;30:442–7.
   PubMed Web of Science ®Google Scholar
• Fanchin R, Taieb J, Lozano DH, et al. High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 2005;20:923–7.
   PubMed Web of Science ®Google Scholar
• Van Disseldorp J, Lambalk CB, Kwee J, et al. Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod 2010;25:221–7.
   PubMed Web of Science ®Google Scholar
• Tran ND, Cedars MI, Rosen MP. The role of anti-müllerian hormone (AMH) in assessing ovarian reserve. J Clin Endocrinol Metab 2011;96:3609–14.
   PubMed Web of Science ®Google Scholar
• Pigny P, Merlen E, Robert Y, et al. Elevated serum level of AMH in patient with PCOS: relationship to the ovarion follicle excess to the follicular arrest. J Clin Endocrinol Metab 2003;88:5957–62.
   PubMed Web of Science ®Google Scholar
• Karkanaki A, Vosnakis C, Panidis D, et al. The clinical significance of anti-Mullerian hormone evaluation in gynecological endocrinology. Hormones 2011;10:95–103.
   PubMedGoogle Scholar
• Fanchin R, Louafi N, Mendez Lozano DH, et al. Per-follicle measurements indicate that anti-mullerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status. Fertil Steril 2005;84:167–73.
   PubMed Web of Science ®Google Scholar
• Christiansen SC, Eilertsen TB, Vanky E, Carlsen SM. Does AMH reflect follicle number similarly in women with and without PCOS? PLoS One 2016;11:e0146739.
   PubMed Web of Science ®Google Scholar
• Pellatt L, Hanna L, Brincat M, et al. Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab 2007;92:240–5.
   PubMed Web of Science ®Google Scholar
• Das M, Gillott DJ, Saridogan E, Djahanbakhch O. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome. Hum Reprod 2008;23:2122–6.
   PubMed Web of Science ®Google Scholar
• Chen Y, Ye B, Yang Xiaojing Y, et al. Predicting the outcome of different protocols of in vitro fertilization with anti-mullerian hormone levels in patients with polycystic ovary syndrome. J Intern Med Res 2017;45:1138–47.
   PubMed Web of Science ®Google Scholar
• Knez J, Kovacic B, Medved M, Vlaisavljevic V. What is the value of anti-Mullerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols? Reprod Biol Endocrinol 2015;13:58.
   PubMed Web of Science ®Google Scholar
• Broer SL, Dolleman M, van Disseldorp J, et al. Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis. Fertil Steril 2013;100:420–9.
   PubMed Web of Science ®Google Scholar
• Palomba S, Falbo A, La Sala GB. Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: a systematic review with meta-analysis of randomized controlled trials. Reprod Biol Endocrinol 2014;12:3.
   PubMed Web of Science ®Google Scholar
• La Marca A, Morgante G, Palumbo M, et al. Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. Fertil Steril 2002;78:1234–9.
   PubMed Web of Science ®Google Scholar
• Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 2008;14:367–78.
   PubMed Web of Science ®Google Scholar
• La Marca A, Orvieto R, Giulini S, et al. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertil Steril 2004;82:970–2.
   PubMed Web of Science ®Google Scholar
• Bhide P, Homburg R. Anti Mullerian hormone and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2016;37:38–45.
   PubMed Web of Science ®Google Scholar
• Carlsen SM, Vanky E, Fleming R. Anti-mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome. Hum Reprod 2009;24:1732–8.
   PubMed Web of Science ®Google Scholar
• Caglar GS, Kahyaoglu I, Pabuccu R, et al. Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS. Arch Gynecol Obstet 2013;288:905–10.
   PubMed Web of Science ®Google Scholar
• Tian X, Ruan X, Mueck AO, et al. Serum anti-Mullerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China. Gynecol Endocrinol 2014;30:836–9.
   PubMed Web of Science ®Google Scholar
• Fonseca HP, Brondi RS, Piovesan FX, et al. Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome. Gynecol Endocrinol 2014;30:667–70.
   PubMed Web of Science ®Google Scholar
• Tokmak A, Kokanali D, Timur H, et al. Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome. Gynecol Endocrinol 2016;32:926–30.
   PubMed Web of Science ®Google Scholar
• Fanchin R, Mendez Lozano DH, Frydman N, et al. Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. J Clin Endocrinol Metab 2007;92:1796–802.
   PubMed Web of Science ®Google Scholar
• Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L. Prediction of high ovarian response to controlled ovarian hyperstimulation: anti Mullerian hormone versus small antral follicle count (2-6 mm). J Assist Reprod Genet 2009;26:319–25.
   PubMed Web of Science ®Google Scholar
• Cupisti S, Dittrich R, Mueeler A, et al. Correlations between anti-Mullerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes. Eur J Med Res 2007;12:604–8.
   PubMed Web of Science ®Google Scholar
• Takahashi C, Fujito A, Kazuka M, et al. Anti-Mullerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization. Fertil Steril 2008;89:586–91.
   PubMed Web of Science ®Google Scholar
• Lie Fong S, Baart EB, Martini E, et al. Anti-Mullerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online 2008;16:664–70.
   PubMed Web of Science ®Google Scholar
• Smeenk JM, Sweep FC, Zielhuis GA, et al. Antimullerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril 2007;87:223–6.
   PubMed Web of Science ®Google Scholar
• Eldar-Geva T, Margalioth EJ, Gal M, et al. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod 2005;20:1814–19.
   PubMed Web of Science ®Google Scholar
• Laven JS, Mulders AG, Visser JA, et al. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 2004;89:318–23.
   PubMed Web of Science ®Google Scholar
• Penarrubia J, Fabregues F, Manau D, et al. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Hum Reprod 2005;20:915–22.
   PubMed Web of Science ®Google Scholar